Atlas Trials

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

Clinical trial NCT00088049 · COMPLETED

Trial details

NCT number
NCT00088049
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2003-10-01
Enrollment
560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.